Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04986956 · ClinicalTrials.gov registry record · NA
Whole Coffee Cherry Study
A NA study, sponsored by Auburn University.
- Completed
- Registry status
- NA
- Development phase
- 323
- Enrollment target
NCT04986956 is a NA study that has completed, run by Auburn University. The registered enrollment target is 323 participants.
The verdict
NCT04986956, a NA study, has completed, sponsored by Auburn University.
- COMPLETED
- Registry status
- NA
- Development phase
- 323 participants
- Enrollment target
Study Summary
There has been increasing interest in natural dietary supplements that may support healthy cognition. Recent studies have demonstrated promising effects of bioactive phytochemicals (e.g., polyphenols) on cardiovascular and endocrine health outcomes. As such, an increasingly intriguing line of inquiry is whether materials high in these compounds may also have effects on psychological measures. Preliminary evidence suggests that polyphenols may improve cognition, for example, particularly in aging populations. Whole coffee cherry extract (WCCE; otherwise known as the generally-recognized-as-safe (GRAS) supplement Neurofactor(TM)), is a proprietary, safe, powdered extract of whole coffee cherries from coffea arabica with high levels of polyphenols and substantially low (\<2%; \<4mg) levels of caffeine. WCCE has been previously associated with increased serum concentrations of both circulating and exosomal brain derived neurotrophic factor (BDNF), in addition to increased alertness and decreased fatigue. However, few well-powered and well-designed studies have been conducted despite the mounting preliminary evidence. Here, the investigators propose a study to examine the long-term effects of a 200mg dose of WCCE on measures of cognition.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Whole coffee cherry extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2024-01-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04986956
The ClinicalTrials.gov registry entry for NCT04986956 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 323 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Auburn University, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04986956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04986956 about?
NCT04986956 is a clinical study titled "Whole Coffee Cherry Study". There has been increasing interest in natural dietary supplements that may support healthy cognition. Recent studies have demonstrated promising effects of bioactive phytochemicals (e.g., polyphenols) on cardiovascular and endocrine health outcomes. As such, an increasingly intriguing line of inquir...
What is the current status of trial NCT04986956?
This trial is currently completed. It is a NA study. The enrollment target is 323 participants. The study started on 2022-02-01. Estimated completion is 2024-01-29.
What interventions are being tested in trial NCT04986956?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Whole coffee cherry extract (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04986956?
This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.